Publication Information

{'id': 'https://openalex.org/W2078842080', 'doi': 'https://doi.org/10.1111/j.1468-1293.2004.00192.x', 'title': 'Treatment of HIV‐infected patients with a combination of efavirenz, nevirapine and nucleoside reverse transcriptase inhibitors', 'display_name': 'Treatment of HIV‐infected patients with a combination of efavirenz, nevirapine and nucleoside reverse transcriptase inhibitors', 'publication_year': 2004, 'publication_date': '2004-03-01', 'ids': {'openalex': 'https://openalex.org/W2078842080', 'doi': 'https://doi.org/10.1111/j.1468-1293.2004.00192.x', 'mag': '2078842080', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/15012654'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1111/j.1468-1293.2004.00192.x', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S56736983', 'display_name': 'HIV Medicine', 'issn_l': '1464-2662', 'issn': ['1464-2662', '1468-1293'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320595', 'host_organization_name': 'Wiley', 'host_organization_lineage': ['https://openalex.org/P4310320595'], 'host_organization_lineage_names': ['Wiley'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'letter', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5113637902', 'display_name': 'JA Arranz‐Caso', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210106572', 'display_name': 'Hospital Universitario Príncipe de Asturias', 'ror': 'https://ror.org/01az6dv73', 'country_code': 'ES', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210106572', 'https://openalex.org/I4210139293']}], 'countries': ['ES'], 'is_corresponding': False, 'raw_author_name': 'JA Arranz‐Caso', 'raw_affiliation_strings': ['Infectious Diseases Unit, Hospital Príncipe de Asturias, Alcalá de Henares, Spain,'], 'affiliations': [{'raw_affiliation_string': 'Infectious Diseases Unit, Hospital Príncipe de Asturias, Alcalá de Henares, Spain,', 'institution_ids': ['https://openalex.org/I4210106572']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5112246922', 'display_name': 'Miguel Górgolas', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210129357', 'display_name': 'Hospital Universitario Fundación Jiménez Díaz', 'ror': 'https://ror.org/049nvyb15', 'country_code': 'ES', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210129357']}], 'countries': ['ES'], 'is_corresponding': False, 'raw_author_name': 'M Gorgolas', 'raw_affiliation_strings': ['Infectious Diseases Unit, Fundación Jiménez Díaz, Madrid, Spain,'], 'affiliations': [{'raw_affiliation_string': 'Infectious Diseases Unit, Fundación Jiménez Díaz, Madrid, Spain,', 'institution_ids': ['https://openalex.org/I4210129357']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5005269604', 'display_name': 'Vicente Estrada', 'orcid': 'https://orcid.org/0000-0002-7795-5986'}, 'institutions': [], 'countries': ['ES'], 'is_corresponding': False, 'raw_author_name': 'V Estrada', 'raw_affiliation_strings': ['HIV Unit, Hospital Clínico, Madrid, Spain, and'], 'affiliations': [{'raw_affiliation_string': 'HIV Unit, Hospital Clínico, Madrid, Spain, and', 'institution_ids': []}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5107844799', 'display_name': 'JD García‐Diaz', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210106572', 'display_name': 'Hospital Universitario Príncipe de Asturias', 'ror': 'https://ror.org/01az6dv73', 'country_code': 'ES', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210106572', 'https://openalex.org/I4210139293']}], 'countries': ['ES'], 'is_corresponding': False, 'raw_author_name': 'JD García‐Diaz', 'raw_affiliation_strings': ['Clinical Research Unit, Hospital Príncipe de Asturias, Alcalá de Henares, Spain'], 'affiliations': [{'raw_affiliation_string': 'Clinical Research Unit, Hospital Príncipe de Asturias, Alcalá de Henares, Spain', 'institution_ids': ['https://openalex.org/I4210106572']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 2, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': {'value': 3760, 'currency': 'USD', 'value_usd': 3760, 'provenance': 'doaj'}, 'apc_paid': None, 'fwci': None, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 4, 'citation_normalized_percentile': {'value': 0.259854, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 74, 'max': 76}, 'biblio': {'volume': '5', 'issue': '2', 'first_page': '128', 'last_page': '129'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10526', 'display_name': 'HIV/AIDS drug development and treatment', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2725', 'display_name': 'Infectious Diseases'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10526', 'display_name': 'HIV/AIDS drug development and treatment', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2725', 'display_name': 'Infectious Diseases'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T12369', 'display_name': 'Pneumocystis jirovecii pneumonia detection and treatment', 'score': 0.9989, 'subfield': {'id': 'https://openalex.org/subfields/2713', 'display_name': 'Epidemiology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10082', 'display_name': 'HIV/AIDS Research and Interventions', 'score': 0.9987, 'subfield': {'id': 'https://openalex.org/subfields/2725', 'display_name': 'Infectious Diseases'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/nevirapine', 'display_name': 'Nevirapine', 'score': 0.9325355}, {'id': 'https://openalex.org/keywords/efavirenz', 'display_name': 'Efavirenz', 'score': 0.9260166}, {'id': 'https://openalex.org/keywords/didanosine', 'display_name': 'Didanosine', 'score': 0.8071381}, {'id': 'https://openalex.org/keywords/regimen', 'display_name': 'Regimen', 'score': 0.7032174}, {'id': 'https://openalex.org/keywords/stavudine', 'display_name': 'Stavudine', 'score': 0.6674223}, {'id': 'https://openalex.org/keywords/reverse-transcriptase-inhibitor', 'display_name': 'Reverse-transcriptase inhibitor', 'score': 0.5964182}], 'concepts': [{'id': 'https://openalex.org/C2779130552', 'wikidata': 'https://www.wikidata.org/wiki/Q263713', 'display_name': 'Nevirapine', 'level': 5, 'score': 0.9325355}, {'id': 'https://openalex.org/C2781432083', 'wikidata': 'https://www.wikidata.org/wiki/Q422645', 'display_name': 'Efavirenz', 'level': 5, 'score': 0.9260166}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.8103917}, {'id': 'https://openalex.org/C2777447569', 'wikidata': 'https://www.wikidata.org/wiki/Q422606', 'display_name': 'Didanosine', 'level': 5, 'score': 0.8071381}, {'id': 'https://openalex.org/C2781413609', 'wikidata': 'https://www.wikidata.org/wiki/Q7308373', 'display_name': 'Regimen', 'level': 2, 'score': 0.7032174}, {'id': 'https://openalex.org/C2779889181', 'wikidata': 'https://www.wikidata.org/wiki/Q423984', 'display_name': 'Stavudine', 'level': 5, 'score': 0.6674223}, {'id': 'https://openalex.org/C2777869810', 'wikidata': 'https://www.wikidata.org/wiki/Q422631', 'display_name': 'Lamivudine', 'level': 4, 'score': 0.631845}, {'id': 'https://openalex.org/C2777351918', 'wikidata': 'https://www.wikidata.org/wiki/Q421559', 'display_name': 'Reverse-transcriptase inhibitor', 'level': 5, 'score': 0.5964182}, {'id': 'https://openalex.org/C197934379', 'wikidata': 'https://www.wikidata.org/wiki/Q2047938', 'display_name': 'Adverse effect', 'level': 2, 'score': 0.5821155}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.51759636}, {'id': 'https://openalex.org/C2909970146', 'wikidata': 'https://www.wikidata.org/wiki/Q421559', 'display_name': 'Nucleoside Reverse Transcriptase Inhibitor', 'level': 5, 'score': 0.44307676}, {'id': 'https://openalex.org/C2779343474', 'wikidata': 'https://www.wikidata.org/wiki/Q3109175', 'display_name': 'Context (archaeology)', 'level': 2, 'score': 0.4356879}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.42487824}, {'id': 'https://openalex.org/C159047783', 'wikidata': 'https://www.wikidata.org/wiki/Q7215', 'display_name': 'Virology', 'level': 1, 'score': 0.4087312}, {'id': 'https://openalex.org/C90924648', 'wikidata': 'https://www.wikidata.org/wiki/Q120569', 'display_name': 'Gastroenterology', 'level': 1, 'score': 0.39094284}, {'id': 'https://openalex.org/C142462285', 'wikidata': 'https://www.wikidata.org/wiki/Q2528140', 'display_name': 'Viral load', 'level': 3, 'score': 0.3252775}, {'id': 'https://openalex.org/C3013748606', 'wikidata': 'https://www.wikidata.org/wiki/Q15787', 'display_name': 'Human immunodeficiency virus (HIV)', 'level': 2, 'score': 0.23011133}, {'id': 'https://openalex.org/C2993143319', 'wikidata': 'https://www.wikidata.org/wiki/Q583050', 'display_name': 'Antiretroviral therapy', 'level': 4, 'score': 0.18761188}, {'id': 'https://openalex.org/C2522874641', 'wikidata': 'https://www.wikidata.org/wiki/Q808', 'display_name': 'Virus', 'level': 2, 'score': 0.16719529}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.07970476}, {'id': 'https://openalex.org/C2780593183', 'wikidata': 'https://www.wikidata.org/wiki/Q6844', 'display_name': 'Hepatitis B virus', 'level': 3, 'score': 0.0}, {'id': 'https://openalex.org/C151730666', 'wikidata': 'https://www.wikidata.org/wiki/Q7205', 'display_name': 'Paleontology', 'level': 1, 'score': 0.0}], 'mesh': [{'descriptor_ui': 'D015658', 'descriptor_name': 'HIV Infections', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D019829', 'descriptor_name': 'Nevirapine', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': True}, {'descriptor_ui': 'D009705', 'descriptor_name': 'Nucleosides', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': True}, {'descriptor_ui': 'D010078', 'descriptor_name': 'Oxazines', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': True}, {'descriptor_ui': 'D018894', 'descriptor_name': 'Reverse Transcriptase Inhibitors', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': True}, {'descriptor_ui': 'D000328', 'descriptor_name': 'Adult', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000480', 'descriptor_name': 'Alkynes', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D048588', 'descriptor_name': 'Benzoxazines', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D003521', 'descriptor_name': 'Cyclopropanes', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004359', 'descriptor_name': 'Drug Therapy, Combination', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005260', 'descriptor_name': 'Female', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D015658', 'descriptor_name': 'HIV Infections', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008297', 'descriptor_name': 'Male', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D019829', 'descriptor_name': 'Nevirapine', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D019829', 'descriptor_name': 'Nevirapine', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D009705', 'descriptor_name': 'Nucleosides', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D009705', 'descriptor_name': 'Nucleosides', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D010078', 'descriptor_name': 'Oxazines', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D010078', 'descriptor_name': 'Oxazines', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D010865', 'descriptor_name': 'Pilot Projects', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D018894', 'descriptor_name': 'Reverse Transcriptase Inhibitors', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D018894', 'descriptor_name': 'Reverse Transcriptase Inhibitors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D016896', 'descriptor_name': 'Treatment Outcome', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1111/j.1468-1293.2004.00192.x', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S56736983', 'display_name': 'HIV Medicine', 'issn_l': '1464-2662', 'issn': ['1464-2662', '1468-1293'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320595', 'host_organization_name': 'Wiley', 'host_organization_lineage': ['https://openalex.org/P4310320595'], 'host_organization_lineage_names': ['Wiley'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/15012654', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'id': 'https://metadata.un.org/sdg/3', 'score': 0.85, 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 2, 'referenced_works': ['https://openalex.org/W2084136477', 'https://openalex.org/W2180761483'], 'related_works': ['https://openalex.org/W4233639601', 'https://openalex.org/W283351130', 'https://openalex.org/W2466287370', 'https://openalex.org/W2414012236', 'https://openalex.org/W2395036434', 'https://openalex.org/W2374691723', 'https://openalex.org/W2358553399', 'https://openalex.org/W2054105441', 'https://openalex.org/W1994966130', 'https://openalex.org/W159595500'], 'abstract_inverted_index': {'Recently,': [0], 'the': [1, 4, 76, 83, 96, 114, 124, 127, 227, 260, 278, 308, 319, 384, 394, 408, 420, 433, 464, 476, 480, 502, 541, 659, 671, 694, 698, 702, 714, 793, 824, 841, 872, 877, 888, 891, 910, 951, 987, 1002], 'results': [2, 77, 1003], 'of': [3, 19, 54, 57, 91, 98, 102, 116, 129, 164, 177, 206, 229, 257, 280, 289, 299, 318, 369, 412, 445, 452, 456, 469, 494, 518, 563, 573, 621, 628, 632, 654, 663, 668, 675, 690, 722, 732, 744, 752, 767, 840, 861, 879, 890, 941, 955, 989, 1019], '2NN': [5, 48, 84, 873, 911], 'study': [6, 12, 119, 874, 892, 993], 'have': [7, 792], 'been': [8], 'reported': [9, 74, 858, 933], '[1].': [10, 913], 'This': [11, 817, 852], 'was': [13, 69, 244, 259, 282, 305, 381, 441, 461, 586, 779, 826, 893, 994, 998], 'an': [14, 450, 626], 'open-label,': [15], 'randomized,': [16], 'comparative': [17], 'trial': [18], 'first-line': [20], 'antiretroviral': [21, 684, 967], 'therapy': [22, 151, 664, 808], 'with': [23, 50, 60, 135, 154, 208, 216, 226, 232, 238, 449, 489, 501, 530, 625, 729, 755, 771, 813, 859, 895, 898, 903, 937, 1015], 'regimens': [24, 146, 725, 759, 860], 'based': [25], 'on': [26, 543, 566], 'stavudine': [27], '(d4T)': [28], 'plus': [29, 32, 104, 249, 739], 'lamivudine': [30], '(3TC)': [31], 'either': [33, 141], 'efavirenz': [34], '(EFV),': [35], 'nevirapine': [36], '(NVP)': [37], 'or': [38, 147, 235, 328, 342, 575], 'both': [39, 123], 'nonnucleoside': [40], 'reverse': [41, 137], 'transcriptase': [42, 138], 'inhibitors': [43, 139], '(NNRTIs)': [44], 'taken': [45, 311], 'simultaneously': [46], '(the': [47], 'group),': [49], 'a': [51, 65, 117, 149, 223, 252, 273, 490, 647, 730, 928, 938, 999, 1006, 1016], 'dose': [52, 256, 279], 'adjustment': [53], '800': [55, 285], 'mg': [56, 62, 263, 271, 286, 330, 338, 344, 353], 'EFV': [58, 79, 105, 132, 218, 281, 304, 734, 791, 1011], 'dosed': [59], '400': [61, 329], 'NVP': [63, 103, 130, 258, 293, 312, 789, 899, 904, 1009], 'once': [64, 683, 905, 966], 'day': [66, 274], '(qd).': [67], 'There': [68, 511, 533], 'no': [70, 720], 'statistically': [71], 'significant': [72], 'difference': [73], 'between': [75, 292, 701], 'for': [78, 197, 240, 265, 313, 466], 'and': [80, 126, 131, 169, 180, 190, 202, 219, 294, 350, 361, 367, 374, 376, 386, 393, 396, 429, 463, 486, 523, 607, 644, 665, 677, 704, 717, 735, 790, 796, 868, 907, 957, 960, 996, 1010], 'NVP,': [81, 217, 733], 'but': [82, 277, 506], 'group': [85, 174, 203, 516, 538, 546, 560, 590, 593, 605, 610, 783, 786, 829, 833, 912], 'showed': [86, 641, 666], 'lower': [87], 'treatment': [88, 544, 567, 770, 850, 862], 'efficacy': [89, 128], 'because': [90, 288, 411], 'increased': [92, 283], 'adverse': [93, 236, 414, 423, 601, 845, 1020], 'events.': [94], 'On': [95], 'basis': [97], 'these': [99], 'results,': [100, 875], 'use': [101], 'is': [106, 854, 916, 973, 1013], 'not': [107, 406, 417, 569, 763], 'recommended.': [108], 'In': [109, 559, 707, 835, 919], 'this': [110, 242, 708, 772, 992], 'context,': [111], 'we': [112], 'report': [113], 'findings': [115], 'pilot': [118], 'conducted': [120], 'to': [121, 284, 297, 333, 347, 390, 399, 432, 592, 681, 785, 837, 849, 871, 964, 981], 'investigate': [122], 'tolerance': [125], 'in': [133, 142, 152, 222, 251, 419, 474, 515, 537, 545, 583, 589, 604, 609, 776, 782, 828, 832, 909, 934, 991], 'combination': [134, 731], 'nucleoside': [136], '(NRTIs),': [140], 'protease': [143], 'inhibitor': [144], '(PI)-sparing': [145], 'as': [148, 443, 619, 806], 'second-line': [150], 'patients': [153, 160, 179, 181, 207, 213, 231, 309, 356, 498, 514, 536, 542, 565, 597, 614, 695, 711, 754, 842, 880, 923, 990], 'failing': [155, 209, 724, 757], 'PI-based': [156, 210, 758], 'regimens.': [157, 211, 532], 'Thirty': [158], 'consecutive': [159], 'without': [161], 'previous': [162, 185, 233, 723, 756], 'experience': [163, 234], 'NNRTIs': [165], 'were': [166, 214, 322, 357, 416, 425, 472, 484, 512, 521, 534, 686, 696, 969, 978], 'enrolled': [167], 'prospectively': [168], 'divided': [170], 'into': [171], 'two': [172, 613, 634, 640, 652, 922, 947], 'groups:': [173], '1': [175, 314, 547, 591, 606, 784, 830], 'consisted': [176, 205], 'treatment-naïve': [178, 522], 'who': [182, 191, 712, 718, 881], 'had': [183, 192, 310, 499, 508, 525, 548, 576, 599, 635, 646, 719, 741, 843, 924], 'undergone': [184, 527], 'treatments': [186], 'that': [187, 404, 847, 857, 863, 976, 1005], 'included': [188, 418], 'PIs': [189], 'viral': [193, 370, 742], 'loads': [194, 743], '<50': [195, 745], 'copies/mL': [196, 554, 746], 'at': [198, 359, 555, 747, 819], 'least': [199, 820], '6': [200, 362, 556, 748], 'months,': [201, 749], '2': [204, 594, 611], 'All': [212, 355, 540], 'treated': [215, 728], 'didanosine': [220], '(ddI)': [221], 'triple': [224], 'regimen,': [225, 700], 'exception': [228], 'nine': [230, 487], 'effects': [237, 415, 846], 'ddI,': [239, 326], 'whom': [241, 519], 'drug': [243], 'substituted': [245], 'by': [246, 269, 364], 'zidovudine': [247], '(ZDV)/d4T': [248], '3TC,': [250, 351], 'quadruple': [253], 'regimen.': [254, 773], 'The': [255, 316, 581, 651, 688, 774, 946], 'usual': [261], '200': [262, 270], 'qd': [264, 287, 331], '15': [266], 'days': [267], 'followed': [268, 473], 'twice': [272, 900], '(bid)': [275], 'indefinitely,': [276], 'pharmacological': [290], 'interference': [291], 'EFV,': [295, 896], 'according': [296, 431], 'data': [298], 'Veldkamp': [300], 'et': [301], 'al.': [302], '[2].': [303], 'added': [306], 'after': [307, 769], 'month.': [315], 'doses': [317], 'other': [320], 'drugs': [321, 685, 968], 'those': [323], 'commonly': [324], 'used:': [325], '250': [327, 337], 'adjusted': [332, 346], 'body': [334, 348], 'weight;': [335], 'ZDV,': [336], 'bid;': [339], 'd4T,': [340], '30': [341, 481], '40': [343], 'bid': [345], 'weight,': [349], '150': [352], 'bid.': [354], 'reevaluated': [358], '3': [360], 'months': [363, 557], 'clinical': [365, 477, 616, 655, 678, 925, 961, 1023], 'assessment': [366], 'determination': [368], 'load': [371], '(VL),': [372], 'CD4,': [373], 'biochemical': [375], 'haematological': [377], 'parameters.': [378], 'Statistical': [379], 'analysis': [380], 'performed': [382], 'using': [383], 'χ2': [385], "Fisher's": [387], 'exact': [388], 'tests': [389], 'compare': [391, 400], 'proportions,': [392], 't-test': [395], 'Mann–Whitney': [397], 'test': [398], 'continuous': [401], 'variables.': [402], 'Patients': [403], 'did': [405, 568, 762], 'complete': [407, 699], 'follow-up': [409, 715], 'period': [410, 716], 'secondary': [413], 'analysis.': [421], 'Severe': [422], 'events': [424], 'considered': [426], 'grades': [427], 'III': [428], 'IV': [430], 'World': [434], 'Health': [435], 'Organization': [436], '(WHO)': [437], 'classification.': [438], 'Clinical': [439], 'hepatitis': [440, 503, 617, 656, 942, 982], 'defined': [442], 'symptoms': [444, 620, 679, 962], 'liver': [446, 622], 'disease': [447, 623], 'associated': [448, 624, 1014], 'elevation': [451, 627], '>3-fold': [453], 'normal': [454, 630, 672, 682, 965], 'levels': [455, 572, 631, 766], 'transaminases.': [457], 'Appropriate': [458], 'informed': [459], 'consent': [460], 'obtained,': [462], 'guidelines': [465], 'human': [467], 'experimentation': [468], 'our': [470, 920], 'institution': [471], 'conducting': [475], 'research.': [478], 'Of': [479], 'patients,': [482], '21': [483], 'male': [485], 'female,': [488], 'mean': [491], '(±SD)': [492], 'age': [493], '38±7': [495], 'years.': [496], 'Twenty': [497], 'coinfection': [500], 'C': [504, 943, 983], 'virus,': [505], 'none': [507], 'portal': [509], 'hypertension.': [510], '19': [513], '1,': [517], 'three': [520, 608, 645], '16': [524], 'previously': [526], 'successful': [528], 'HAART': [529], 'PI': [531], '11': [535], '2.': [539, 787, 834], 'less': [549], 'than': [550, 831, 856, 932], '50': [551], 'HIV-1': [552], 'RNA': [553], 'follow-up.': [558], '2,': [561], 'six': [562, 603, 751], 'eight': [564, 753], 'achieve': [570, 764], 'undetectable': [571, 765], 'HIV': [574, 768], 'early': [577], 'rebound': [578], '(P=': [579], '0.002).': [580], 'increase': [582, 775], 'CD4': [584, 777], 'count': [585, 778], 'also': [587, 780], 'superior': [588, 781], '(P=0.06).': [595], 'Nine': [596], '(30%)': [598], 'severe': [600, 648, 844], 'effects,': [602, 1021], '(P=1):': [612], 'developed': [615], '(defined': [618], '>5-fold': [629, 670], 'transaminases);': [633], 'central': [636], 'nervous': [637], 'system': [638], 'disturbances;': [639], 'gastric': [642], 'intolerance,': [643], 'skin': [649], 'rash.': [650], 'cases': [653, 689, 948], 'occurred': [657, 949], 'within': [658, 950], 'first': [660, 952], '12': [661, 953], 'weeks': [662, 954], 'values': [667, 959], 'transaminases': [669, 676], 'range.': [673], 'Values': [674], 'returned': [680, 963], 'discontinued.': [687], 'rash': [691], 'appeared': [692], 'when': [693, 809], 'taking': [697], '4th': [703], '8th': [705], 'weeks.': [706], 'study,': [709, 921, 1001], 'all': [710], 'completed': [713], 'history': [721], '(group': [726, 760], '1)': [727], 'ddI': [736], '(or': [737], 'ZDV/d4T': [738], '3TC)': [740], 'whereas': [750], '2)': [761], 'Because': [788], 'same': [794], 'target': [795], 'similar': [797, 870, 939], 'genetic': [798], 'resistance': [799], 'barriers': [800], '[3,': [801], '4],': [802], 'they': [803, 810, 977], 'probably': [804], 'act': [805], 'double': [807], 'are': [811], 'combined': [812], 'only': [814, 865], 'one': [815, 866], 'NRTI.': [816], 'could': [818], 'partially': [821], 'explain': [822], 'why': [823], 'effect': [825], 'better': [827], 'relation': [836], 'toxicity,': [838], '30%': [839], 'led': [848], 'interruption.': [851], 'percentage': [853, 929], 'higher': [855, 931, 1017], 'include': [864], 'NNRTI': [867, 886], 'very': [869, 974], 'where': [876], 'proportion': [878, 940], 'came': [882], 'off': [883], 'their': [884], 'randomized': [885], 'during': [887], 'course': [889], '20%': [894], '22%': [897], 'daily,': [901, 906], '29.1%': [902], '34.5%': [908], 'Particularly': [914], 'worrying': [915], 'hepatic': [917], 'toxicity.': [918], 'hepatitis,': [926], 'i.e.': [927], '(6.3%)': [930], 'others': [935], 'works,': [936], 'virus': [944, 984], 'coinfection.': [945], 'therapy,': [956], 'transaminase': [958], 'discontinued,': [970], 'so': [971], 'it': [972, 997], 'unlikely': [975], 'attributable': [979], 'solely': [980], 'infection.': [985], 'Although': [986], 'number': [988], 'small': [995], 'noncomparative': [1000], 'suggest': [1004], 'regimen': [1007], 'including': [1008], 'together': [1012], 'incidence': [1018], 'principally': [1022], 'hepatitis.': [1024]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2078842080', 'counts_by_year': [], 'updated_date': '2024-12-09T08:41:57.719169', 'created_date': '2016-06-24'}